The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.22
Bid: 16.22
Ask: 16.34
Change: 0.54 (3.44%)
Spread: 0.12 (0.74%)
Open: 15.40
High: 16.28
Low: 15.40
Prev. Close: 15.68
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Confirmation of sanction of Scheme of Arrangement

16 Nov 2016 15:43

RNS Number : 3757P
EnQuest PLC
16 November 2016
 

ENQUEST PLC, 16 November 2016

 

Confirmation of sanction of the Scheme of Arrangement

 

US$650,000,000 7 per cent. Senior Notes due 2022 (CUSIP: Rule 144A Notes: 29357JAA4;

Regulation S Notes G315APAB4; ISIN: Rule 144A Notes US29357JAA43; Regulation S Notes

USG315APAB40) (the "High Yield Notes")

 

and

 

£155,000,000 5.50 per cent. Notes due 2022 (XS0880578728, Common Code: 088057872)

(the "Retail Notes")

 

(the High Yield Notes and Retail Notes together, the "Notes")

 

Further to the announcement issued by the Company on 15 November 2016, the Company is pleased to announce that the Scheme in connection with the Company's Notes was sanctioned by the High Court of Justice of England and Wales at the Scheme Sanction Hearing which took place before the Honourable Mr Justice Hildyard at 11 a.m. (London time) on 16 November 2016.

 

A copy of the Court Order sanctioning the Scheme has also been delivered to, and acknowledged by, the Registrar of Companies in England and Wales.

 

Successful completion of the Scheme is now conditional on the Company obtaining recognition of the Scheme under chapter 15 of Title 11 of the United States Code and the Scheme otherwise becoming unconditional in accordance with its terms. As noted in previous announcements, each of the elements of the Restructuring (of which the Scheme is an integral part) are inter-conditional, meaning that the Scheme will only become effective if each of the other elements of the Restructuring are approved and / or completed.

 

As noted in the announcement dated 26 October 2016, the Recognition Hearing before the United States Bankruptcy Court of the Southern District of New York to consider granting recognition of the Scheme under chapter 15 of title 11 of the United States Code will take place at 11:00 a.m. (New York time) on 17 November 2016 in Room 617 of the Court, One Bowling Green, New York, New York.

 

Capitalised terms used but not defined in this announcement have the meaning given to them in the Practice Statement Letter.

 

 

Enquiries:

Information Agent:

 

Lucid Issuer Services Limited

 

David Shilson

 

Email: enquest@lucid-is.com

Telephone: +44 (0) 20 7704 0880

Scheme Website: www.lucid-is.com/enquest

   

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SOABFBATMBIBBTF
Date   Source Headline
24th Nov 20207:00 amRNSOperations update
23rd Oct 20208:56 amRNSBoard Appointment
15th Oct 20209:19 amRNSMaturity date extension: High Yield & Retail Notes
17th Sep 202010:07 amRNSDirector/PDMR Shareholding
14th Sep 20209:22 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSEnQuest PLC Half Year Results 2020
20th Aug 202011:14 amRNSAdmission to Trading
31st Jul 20207:00 amRNSEnQuest signs sale and purchase agreement
30th Jul 202010:37 amRNSBond PIK Announcement
29th Jun 20202:11 pmRNSPayments to governments
9th Jun 202012:20 pmRNSDirector/PDMR Shareholding
21st May 20204:20 pmRNSAGM Statement
21st May 20207:00 amRNSOperations update
4th May 202010:22 amRNSDirector/PDMR Shareholding
1st May 20204:26 pmRNSHolding(s) in Company
27th Apr 202010:52 amRNSDirector/PDMR Shareholding
24th Apr 20209:23 amRNSDirector/PDMR Shareholding
23rd Apr 20204:06 pmRNSNotice of AGM and Report & Accounts
21st Apr 202010:31 amRNSDirector/PDMR Shareholding
20th Apr 20203:25 pmRNSDirector/PDMR Shareholding
20th Apr 20202:55 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSEnQuest 2019 Full Year Results
8th Apr 20208:00 amRNSNotification of full year results announcement
2nd Apr 20201:42 pmRNSDirector/PDMR Shareholding
25th Mar 20202:57 pmRNSFull year results update
19th Mar 20204:16 pmRNSDirectorate Change
19th Mar 20207:00 amRNSOperations update
20th Feb 20203:58 pmRNSAdmission to Trading
4th Feb 20207:00 amRNSOperations update
31st Jan 202011:59 amRNSBond PIK Announcement
6th Jan 202012:14 pmRNSTotal Voting Rights
9th Dec 201910:39 amRNSDirector/PDMR Shareholding
4th Dec 201912:48 pmRNSBlock listing Interim Review
4th Dec 20197:00 amRNSEnQuest awarded Block PM409 PSC offshore Malaysia
3rd Dec 20192:32 pmRNSTotal Voting Rights
2nd Dec 20199:22 amRNSDirector/PDMR Shareholding
27th Nov 20198:40 amRNSDirector/PDMR Shareholding
21st Nov 20197:00 amRNSOperations update
28th Oct 201910:33 amRNSDirector/PDMR Shareholding
21st Oct 201910:11 amRNSDirector/PDMR Shareholding
18th Oct 201910:25 amRNSTotal Voting Rights
11th Oct 201912:13 pmRNSDirector/PDMR Shareholding
9th Oct 20194:27 pmRNSDirector/PDMR Shareholding
2nd Oct 20191:08 pmRNSDirector/PDMR Shareholding
17th Sep 201911:25 amRNSHolding(s) in Company
16th Sep 201911:13 amRNSDirector/PDMR Shareholding
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.